Allspring Global Investments Holdings LLC Lowers Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Allspring Global Investments Holdings LLC lowered its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 19.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 131,593 shares of the medical instruments supplier’s stock after selling 32,597 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.06% of DENTSPLY SIRONA worth $4,683,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in XRAY. MetLife Investment Management LLC lifted its stake in DENTSPLY SIRONA by 23.1% in the first quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock worth $2,926,000 after acquiring an additional 11,156 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in DENTSPLY SIRONA by 6.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock worth $1,440,000 after acquiring an additional 1,811 shares during the last quarter. Raymond James Trust N.A. lifted its stake in DENTSPLY SIRONA by 61.7% in the first quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock worth $346,000 after acquiring an additional 2,687 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in DENTSPLY SIRONA by 6.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock worth $90,243,000 after acquiring an additional 117,571 shares during the last quarter. Finally, Sei Investments Co. lifted its stake in DENTSPLY SIRONA by 18.9% in the first quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock worth $23,090,000 after acquiring an additional 74,629 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $30.50 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The company’s fifty day moving average is $32.79 and its two-hundred day moving average is $32.84. DENTSPLY SIRONA Inc. has a 1 year low of $26.27 and a 1 year high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, topping the consensus estimate of $0.43 by $0.01. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The business’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.46 EPS. On average, analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 2.10%. DENTSPLY SIRONA’s payout ratio is currently -103.22%.

Analyst Ratings Changes

A number of research firms have weighed in on XRAY. Piper Sandler raised their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Friday, January 12th. SVB Leerink began coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective on the stock. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Needham & Company LLC reissued a “buy” rating and set a $42.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Finally, Barrington Research reissued an “outperform” rating and set a $41.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of “Moderate Buy” and a consensus target price of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.